Resumo
Objetivo: Mapear ações de gestão do cuidado à saúde que contribuíram para a redução do abandono do tratamento de adultos com tuberculose residentes em países em desenvolvimento. Método: Revisão de escopo que seguiu as recomendações do Joanna Briggs Institute, com buscas realizadas nas bases de dados MEDLINE, CINAHL, Embase, Web of Science, Scopus, LILACS. Resultados: 31 estudos compuseram a amostra final com maior representação de estudos desenvolvidos na África e publicados no ano de 2014 (15,15% cada). Os estudos analisados enfatizam quatro dimensões principais de gestão do cuidado: organização dos serviços de saúde, supervisão da adesão ao tratamento, manejo das reações adversas aos medicamentos e suporte social. Conclusão: As ações de gestão do cuidado identificadas concentraram-se no fortalecimento da estratégia directly observed treatment, short-course, monitoramento clínico e farmacovigilância, uso de tecnologias digitais, atenção farmacêutica e apoio nutricional, além de ações voltadas à educação em saúde, comunicação, aconselhamento, fortalecimento do vínculo e apoio social e familiar. Desse modo, essas intervenções contribuíram para melhorar a adesão ao tratamento e reduzir o abandono terapêutico entre pessoas com tuberculose.
Referências
Ministério da Saúde (BR). Boletim epidemiológico – Tuberculose 2024 [Internet]. Brasília: Ministério da Saúde; 2024 [cited 2026 Jan 22]. Available from: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2024/boletim-epidemiologico-tuberculose-2024/view
Silva A de S, Andrade LG. Linha histórica da tuberculose e o avanço de seu tratamento até os dias atuais. REASE. 2023;9(4):1864-1879. https://doi.org/10.51891/rease.v9i4.9590
Silva ICS, Oliveira RM, Corsino AMR, Inoue KC, Bertão CS, Donadio PR, et al. Tuberculose: interações medicamentosas no tratamento. In: 7º Encontro Anual de Extensão Universitária UEM; 2024 Out. 8-9; Maringá. Maringá: UEM [Internet]; 2024 [cited 2026 Jan 22]. Available from: http://www.eaex.uem.br/eaex2024/anais/artigos/671.pdf
Ministério da Saúde (BR). Manual de recomendações e controle da tuberculose no Brasil [Internet]. 2. ed. Brasília: Ministério da Saúde; 2019 [cited 2026 Jan 22]. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manual-de-recomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf/view
World Health Organization. Global Tuberculosis Report 2021 [Internet]. Geneva: WHO; 2021 [cited 2024 Set 22]. Available from: https://www.who.int/publications/i/item/9789240037021
Organização Pan-Americana de Saúde. Mortes por tuberculose aumentam pela primeira vez em mais uma década devido à Pandemia COVID-19 [Internet]. [local desconhecido]: OPAS; 2021 [cited 2026 Jan 31]. Available from: https://www.paho.org/pt/noticias/14-10-2021-mortes-por-tuberculose-aumentam-pela-primeira-vez-em-mais-uma-decada-devido
Nardell EA. Tuberculose (TB) [Internet]. New Jersey: Manual MSD; 2022 [cited 2026 Jan 31]. Available from: https://www.msdmanuals.com/pt/profissional/doen%C3%A7as-infecciosas/micobact%C3%A9rias/tuberculose-tb
World Health Organization. Global Tuberculosis Report 2022 [Internet]. Geneva: WHO; 2022 [cited 2026 Jan 31]. Available from: https://www.who.int/publications/i/item/9789240061729
World Health Organization. Global tuberculosis report 2023 [Internet]. Geneva: WHO; 2023 [cited 2026 Jan 31]. Available from: https://www.who.int/publications/i/item/9789240083851
Morales CRSN. A epidemiologia da tuberculose e o papel da Estratégia da Saúde da Família no Distrito Federal [monografia na internet]. Brasília: Centro Universitário de Brasília; 2024 [cited 2026 Jan 22]. Available from: https://repositorio.uniceub.br/items/805acd6e-b0cd-43e8-8ec2-fc56a4b4a120
Christovam BP, Porto IS, Oliveira DC de. Nursing care management in hospital settings: the building of a construct. Rev Esc Enferm USP. 2012;46(3):734-41. https://doi.org/10.1590/S0080-62342012000300028. PMID: 22773497.
Laureano BR, Monte F de P, Gomes LCD. O feedback do gestor como estratégia para maximização da produtividade da organização. ERR. 2025;10(4):e8279-e8279. https://doi.org/10.56238/ERR01v10n4-030
Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil, H. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis from updated [Internet]. Adelaide: JBI; 2020 [cited 2026 Jan 31]. Available from: https://doi.org/10.46658/JBIMES-20-12
Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping review (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. https://doi.org/10.7326/M18-0850. PMID: 30178033.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan — a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https://doi.org/10.1186/s13643-016-0384-4. PMID: 27919275.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-6. https://doi.org/10.1016/j.jclinepi.2016.01.021. PMID: 27005575.
Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet. 1998;352(9144):1886-1891. https://doi.org/10.1016/s0140-6736(98)03199-7. PMID: 9863786. [included in the review].
Shakya R, Rao BS, Shrestha B. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal. Kathmandu University Medical Journal [Internet]. 2005 [cited 2026 Feb 10];3(1):45-49. Available from: https://pubmed.ncbi.nlm.nih.gov/16401944/ [included in the review].
Zaka-Ur-Rehman Z, Jamshaid M, Chaudhry A. Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients. Pak J Pharm Sci [Internet]. 2008 [cited 2026 Feb 10];21(2):185-194. Available from: https://pubmed.ncbi.nlm.nih.gov/18390450/
Chhetri AK, Saha A, Verma SC, Palaian S, Mishra P, Shankar PR. Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara. JPMA. J Pak Med Assoc [Internet]. 2008 [cited 2026 Feb 10];58(10):532-536. Available from: https://pubmed.ncbi.nlm.nih.gov/18998303/ [included in the review].
Gabriel AP, Mercado CP. Evaluation of Task Shifting in Community‐Based DOTS Program as an Effective Control Strategy for Tuberculosis. Sci World J. 2011;11(1):2178-2186. https://doi.org/10.1100/2011/984321. PMID: 22125465. [included in the review].
Awaisu A, Nik Mohamed MH, Mohamad Noordin N, Abd Aziz N, Syed Sulaiman SA, Muttalif AR, et al. The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy. 2011;6(1):26. https://doi.org/10.1186/1747-597X-6-26. PMID: 21943384. [included in the review].
Wu S, Xia Y, Lv X, Zhang Y, Tang S, Yang Z, et al. Effect of scheduled monitoring of liver function during anti-tuberculosis treatment in a retrospective cohort in China. BMC Public Health. 2012;12(1):454. https://doi.org/10.1186/1471-2458-12-454. PMID: 22712786. [included in the review].
Lv X, Tang S, Xia Y, Wang X, Yuan Y, Hu D, et al. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study. PloS One. 2013;8(6):e65037. https://doi.org/10.1371/journal.pone.0065037. PMID: 23750225. [included in the review].
Otu AA. Is DOTS an effective strategy for TB control in a developing country? AJRM [Internet]. 2013 [cited 2026 Feb 10];9(1). Available from: https://africa-health.com/wp-content/uploads/2015/10/11.-Patient-compliance.pdf [included in the review].
Kisambu J, Nuwaha F, Sekandi JN. Adherence to treatment and supervision for tuberculosis in a DOTS programme among pastoralists in Uganda. Int J Tuberc Lung Dis. 2014;18(7:799-803. https://doi.org/10.5588/ijtld.13.0753. PMID: 24902555. [included in the review].
Ibrahim LM, Hadjia IS, Nguku P, Waziri NE, Akhimien MO, Patrobas P, et al. Health care workers’ knowledge and attitude towards TB patients under Direct Observation of Treatment in Plateau state Nigeria, 2011. Pan Afr Med J. 2014;18(Suppl 1):8. https://doi.org/10.11694/pamj.supp.2014.18.1.3408. PMID: 25328627. [included in the review].
Bediang G, Stoll B, Elia N, Abena J, Nolna D, Chastonay P, et al. SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study. Trials. 2014;15(1). https://doi.org/10.1186/1745-6215-15-35. PMID: 24460827. [included in the review].
Das M, Isaakidis P, Armstrong E, Gundipudi NR, Babu RB, Qureshi IA, et al. Directly-observed and self-administered tuberculosis treatment in a chronic, low-intensity conflict setting in India. PLoS One. 2014;9(3):e92131. https://doi.org/10.1371/journal.pone.0092131. PMID: 24651176. [included in the review].
Sisay S, Mengistu B, Erku W, Woldeyohannes D. Directly Observed Treatment Short-course (DOTS) for tuberculosis control program in Gambella Regional State, Ethiopia: ten years experience. BMC Research Notes. 2014;7(1):44. https://doi.org/10.1186/1756-0500-7-44. PMID: 24444379. [included in the review].
Snidal SJ, Barnard G, Atuhairwe E, Amor YB. Use of eCompliance, an innovative biometric system for monitoring of tuberculosis treatment in rural Uganda. Am J Trop Med Hyg. 2015;92(6):1271. https://doi.org/10.4269/ajtmh.14-0413. PMID: 25846297. [included in the review].
Chu NH, Li L, Zhang X, Gu J, Du YD, Cai C, et al. Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease. Int J Tuberc Lung Dis. 2015;19(4):475-480. https://doi.org/10.5588/ijtld.14.0579. PMID: 25860005. [included in the review].
Amagon KI, Awodele O, Akindele AJ. Methionine and vitamin B‐complex ameliorate antitubercular drugs‐induced toxicity in exposed patients. Pharma Res Per. 2017;5(5):e00360. https://doi.org/10.1002/prp2.360. PMID: 28971606. [included in the review].
Lopes ARV, Miranda S, Ceccato MGB, Silveira MR, Resende NH, Carvalho WS. Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil. An Acad Bras Ciênc. 2017;89(4):2911-2919. https://doi.org/10.1590/0001-3765201720170301. PMID: 29267800. [included in the review].
Tanani DS, Serragui S, Hammi S,Moussa LA, Soulaymani A, Soulaymani R, et al. National strategy for the integration of pharmacovigilance in the Moroccan TB Control Program. Pan Afr Med J. 2017;26(48). https://doi.org/10.11604/pamj.2017.26.48.7394. PMID: 28451026. [included in the review].
Mansour O, Masini EO, Kim BJ, Kamene M, Githiomi MM, Hanson CL, et al. Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya. Int J Tuberc Lung Dis. 2018;22(6):649-654. https://doi.org/10.5588/ijtld.17.0537. PMID: 29862949. [included in the review].
Park S, Sentissi I, Gil SJ, Park W, Oh B, Son AR, et al. Medication event monitoring system for infectious tuberculosis treatment in Morocco: a retrospective cohort study. Int J Environ Res Public Health. 2019;16(3):412. https://doi.org/10.3390/ijerph16030412. PMID: 30709029. [included in the review].
Mwansa-Kambafwile JRM, Jewett S, Chasela C, Ismail N, Menezes. Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers. BMC Public Health. 2020;20(1):622. https://doi.org/10.1186/s12889-020-08739-w. PMID: 32375743. [included in the review].
Moodley N, Saimen A, Zakhura N, Motau D, Setswe G, Charalambous S, et al. ‘They are inconveniencing us’-exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa. BMC Public Health. 2020;20(1):454. https://doi.org/10.1186/s12889-020-08562-3. PMID: 32252703. [included in the review].
Guo P, Qiao W, Sun W, Liu F, Wang C. Telemedicine technologies and tuberculosis management: a randomized controlled trial. Telemed J E Health. 2020;26(9):1150-1156. https://doi.org/10.1089/tmj.2019.0190. PMID: 31794684. [included in the review].
Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, et al. The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study. BMC infectious diseases. 2020;20(1):623. https://doi.org/10.1186/s12879-020-05354-3. PMID: 32831050. [included in the review].
Mahapatra A, Thiruvengadam K, Nair D, Padmapriyadarsini C, Thomas B, Pati S, et al. Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach. PLoS One. 2024;19(7):e0305855. https://doi.org/10.1371/journal.pone.0305855. PMID: 39012889. [included in the review].
Oh AL, Makmor-Bakry M, Islahudin F, Ting CY, Chan SK, Tie ST. Tuberculosis treatment interruption: a qualitative exploration of barriers, challenges, coping strategies and facilitators in Malaysia. Health Promot Int. 2024;39(6):daae176. https://doi.org/10.1093/heapro/daae176. PMID: 39584467. [included in the review].
Baral T, Gururaj VKS, Manu MK, Kudru CU, Singh J, Mukhopadhyay C, et al. Effect of probiotics supplementation on clinical, humanistic, and safety outcomes in patients with tuberculosis: a prospective cohort study in a tertiary healthcare facility in South India. J Am Nutr Assoc. 2025;45(1):44-51. https://doi.org/10.1080/27697061.2025.2531086. PMID: 40743501. [included in the review].
Xie F, Yao R, Liang L, Wu C, Hu Y, Zhou Y, et al. Evidence‐Based Summary on Medication Adherence Management for Adult Tuberculosis Patients With Multi‐Dimensional Strategies and Practice Framework. J Eval Clin Pract. 2025;31(7):e70280. https://doi.org/10.1111/jep.70280. PMID: 41140059. [included in the review].
Ananda AA, Mondal RK, Sarkar B, Samanta SK. Personalized Tuberculosis Treatment Recommendation System (PTTRS) version 1: A Precision-Medicine Based Application for Recommending Personalized Treatment to Tuberculosis Patients. MedRxiv. 2025;06(23):25330035. https://doi.org/10.1101/2025.06.23.25330035 [included in the review].
Ariyanti F, Nurmansyah MI, Wardani RK, Zilhadia, Kilic B. The impact of health system responsiveness on tuberculosis treatment adherence in public primary healthcare facilities in Indonesia. Clin Epidemiol Glob Health. 2025;34:102107. https://doi.org/10.1016/j.cegh.2025.102107 [included in the review].
Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595. https://doi.org/10.1371/journal.pmed.1002595. PMID: 29969463.
Subbaraman R, Mondesert L de, Musiimenta A, Pai M, Mayer KH, Thomas BE, et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018;3(5):e001018. https://doi.org/10.1136/bmjgh-2018-001018. PMID: 30364330.
Wright CM, Westerkamp L, Korver S, Dobler CC. Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness. BMC Infect Dis. 2015;15:210. https://doi.org/10.1186/s12879-015-0945-5. PMID: 25948059.

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Vitória Meireles Felipe de Souza, Cassia Gonçalves Santos da Silveira, André Luiz de Souza Braga, Adriana Silveira Pereira de Melo, Cristal Santos da Silveira, Barbara Pompeu Christovam

